<DOC>
	<DOCNO>NCT02253823</DOCNO>
	<brief_summary>The objective study characterize effect two dose combination tipranavir/ritonavir ( TPV 500 mg/RTV 100 mg TPV 750 mg/RTV 200 mg ) , administered daily BID , pharmacokinetics efavirenz ( EFV ) , 600 mg daily</brief_summary>
	<brief_title>Multiple Dose Comparison Effect Two Dose Combinations Tipranavir/Ritonavir ( TPV/RTV ) , Pharmacokinetic Characteristics Efavirenz ( Sustiva® ) Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>Ability willingness give write informed consent accordance institutional federal guideline comply investigational nature study related requirement Healthy male females 18 60 year age inclusive Ability swallow numerous large capsule without difficulty Reasonable probability completion study A Body Mass Index ( BMI ) 18 35 kg/m2 Acceptable laboratory value indicate adequate baseline organ function require time screen . Laboratory value consider acceptable severity ≤ Grade 1 base Adult AIDS Clinical Trial Group ( ACTG ) Division Acquired Immunodeficiency Syndrome ( National Institute Allergy Infectious Diseases / National Institutes Health ) ( DAIDS ) Grading Scale . All abnormal laboratory value &gt; Grade 1 ( e.g. , creatine phosphokinase ( CPK ) , amylase , triglyceride ) subject approval Boehringer Ingelheim Pharmaceuticals , Inc. ( BIPI ) clinical monitor Acceptable medical history , physical examination , ECG , Chest Xray require prior enter study Willingness abstain alcohol 48 hour prior Study Day 0 abstain alcohol duration study . In addition , Cabernet Sauvignon must ingest within 15 day prior Day 0 ( Visit 2 ) Willingness abstain ingest grapefruit grapefruit juice within 15 day Day 0 , Visit 2 duration study Willingness abstain ingest Seville orange , garlic supplement , St. John 's Wort , Milk Thistle , methylxanthinecontaining drink food ( coffee , tea , cola , energy drink , chocolate , etc . ) within 72 hour PK sample day [ Visit 3 ( Days 16 ) , Visit 4 ( Days 1215 ) , Visit 5 ( Days 2021 Visit 6 ( Day 22 ) ] Willingness abstain use tobacco product duration study Urine drug screen negative illegal nonprescription drug Negative HIV serology Negative Hepatitis B surface antigen Hepatitis C Female subject reproductive potential : Have positive serum Bhuman chronic gonadotropin ( HCG ) Visit 1 , Have use barrier contraceptive method least 3 month prior Visit 3 ( Day 1 ) , Are willing use reliable method doublebarrier contraception ( diaphragm spermicidal cream/jelly condoms spermicidal foam ) trial 30 day completion/termination , Are breastfeed Participation another trial investigational medicine 30 day prior Day 0 ( Visit 2 ) Use know enzyme alter drug ( phenothiazine , cimetidine , barbiturate , ketoconazole , fluconazole , rifampin , steroid , herbal medication within 30 day prior Day 0 ( Visit 2 ) trial Ingestion grapefruit , grapefruit juice , Cabernet Sauvignon within 15 day prior Day 0 ( Visit 2 ) Ingestion Seville orange , garlic supplement , St. John 's Wort , Milk Thistle , methylxanthinecontaining drink food ( coffee , tea , cola , energy drink , chocolate , etc . ) within 72 hour pharmacokinetics ( PK ) sample day [ Visit 3 ( Days 16 ) , Visit 4 ( Days 1215 ) , Visit 5 ( Days 2021 Visit 6 ( Day 22 ) ] Administration antibiotic within 10 day prior Day 0 ( Visit 2 ) trial Inability comply investigator 's instruction History central nervous system ( CNS ) , gastrointestinal , hepatic , renal disorder within past 60 day . Subjects exclude disorder great sixty day , opinion investigator , subject qualify healthy volunteer History alcohol abuse Excessive cigarettes smoke define great 10 cigarette per day Blood plasma donation within 30 day prior Day 0 ( Visit 2 ) Subjects seat systolic blood pressure either &lt; 100 mm Hg &gt; 150 mm Hg ; rest heart rate either &lt; 50 beats/min &gt; 90 beats/min . For subject rest heart rate 50 , due high fitness level , investigator could discuss exclusion medical monitor casebycase basis Subjects history illness allergy , opinion investigator , might confound result study pose additional risk administer tipranavir , ritonavir efavirenz subject Subjects acute illness within 2 week prior Day 0 ( Visit 2 ) . Subjects take overthecounter drug within 7 day prior Day 0 , ( Visit 2 ) take prescription drug , opinion investigator consultation BIPI clinical monitor pharmacokineticist , might interfere either absorption , distribution metabolism test substance Subjects suffer active form depression Subjects history suicidal ideation Known hypersensitivity tipranavir , ritonavir , efavirenz</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>